Bill

Bill > H2217


MA H2217

MA H2217
Relative to opioid reversal drugs


summary

Introduced
02/27/2025
In Committee
02/27/2025
Crossed Over
Passed
Dead

Introduced Session

194th General Court

Bill Summary

Relative to opioid reversal drugs. Mental Health, Substance Use and Recovery.

AI Summary

This bill amends Massachusetts law to expand access to opioid antagonists (drugs approved by the FDA that can reverse opioid overdoses), primarily by establishing a statewide standing order that allows licensed pharmacists to dispense these drugs without individual patient prescriptions. The bill provides legal protections for pharmacists, physicians, and individuals who dispense or administer opioid antagonists in good faith, ensuring they cannot be criminally or civilly prosecuted or face professional disciplinary action. Pharmacists are required to annually report the number of doses dispensed (without identifying individual patients) and must attempt to bill insurance for the medication when possible. The bill also clarifies that individuals can receive, possess, and administer opioid antagonists to someone experiencing an overdose without legal risk. Additionally, the law mandates that the state's health departments develop regulations to implement these provisions, with the goal of increasing the availability and use of life-saving overdose reversal medications.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Joint Committee on Mental Health, Substance Use and Recovery Hearing (13:00:00 11/3/2025 A-2) (on 11/03/2025)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location
State Bill Page https://malegislature.gov/Bills/194/H2217
BillText https://malegislature.gov/Bills/194/H2217.pdf
Loading...